Press Releases
January 14, 2026
Mars Veterinary Health Publishes 2025 Science Impact Report Highlighting Global Advances in Pet Health
Indeterminate
GlobeNewswire, Inc.
January 14, 2026
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
Governor Abbott Reappoints Three To Texas State Board Of Veterinary Medical Examiners
Gov't Institution
Office of the Texas Governor
Owner: American Government
January 13, 2026
Accelerating Discovery: How the Materials Project Is Helping to Usher in the AI Revolution for Materials Science
Gov't Institution
Berkeley Lab - California
Owner: American Government & University of California
January 13, 2026
Kaneka Medical America LLC Announces U.S. Launch of WaveSelect 1014 Guidewire
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
Strive, Inc. (Nasdaq: ASST) and Semler Scientific (Nasdaq: SMLR) Announce Shareholder Approval for Acquisition of Semler Scientific
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
Indeterminate
GlobeNewswire, Inc.
January 13, 2026
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
MKS Inc. Unveils Photonics Solutions to Advance AI, Quantum, and Biotech at Photonics West 2026
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Incubate Investor Survey: U.S. Policy Will Decide U.S.-China Race for Biotech Leadership
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Interlink Electronics, Inc. Announces the Strategic Hire of Mark Duarte as Director of Business Development, North America
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Engine Technology Forum: Industry Insights, Observations, and Outlook for 2026
Indeterminate
GlobeNewswire, Inc.